Background: This study aimed to compare the long-term survival of patients undergoing minimally invasive gastrectomy and those undergoing open gastrectomy for gastric adenocarcinoma (GA) in the United States and China.
Methods: Data on patients with GA who underwent gastrectomy without neoadjuvant therapy were retrieved from prospectively maintained databases at Memorial Sloan Kettering Cancer Center (MSKCC) and Fujian Medical University Union Hospital (FMUUH). Using propensity score-matching (PSM), equally sized cohorts of patients with similar clinical and pathologic characteristics who underwent minimally invasive versus open gastrectomy were selected. The primary end point of the study was 5-year overall survival (OS).
Results: The study identified 479 patients who underwent gastrectomy at MSKCC between 2000 and 2012 and 2935 patients who underwent gastrectomy at FMUUH between 2006 and 2014. Of the total 3432 patients, 1355 underwent minimally invasive gastrectomy, and 2059 underwent open gastrectomy. All the patients had at least 5 years of potential follow-up evaluation. Before PSM, most patient characteristics differed significantly between the patients undergoing the two types of surgery. After PSM, each cohort included 889 matched patients, and the actual 5-year OS did not differ significantly between the two cohorts, with an OS rate of 54% after minimally invasive gastrectomy and 50.4% after open gastrectomy (p = 0.205). Subgroup analysis confirmed that survival was similar between surgical cohorts among the patients for each stage of GA and for those undergoing distal versus total/proximal gastrectomy. In the multivariable analysis, surgical approach was not an independent prognostic factor.
Conclusions: After PSM of U.S. and Chinese patients with GA undergoing gastrectomy, long-term survival did not differ significantly between the patients undergoing minimally invasive gastrectomy and those undergoing open gastrectomy.
Comparison of Outcomes for Elderly Gastric Cancer Patients at Least 80 Years of Age Following Gastrectomy in the United States and China.Ann Surg Oncol. 2018 Nov;25(12):3629-3638. doi: 10.1245/s10434-018-6757-2. Epub 2018 Sep 14. Ann Surg Oncol. 2018. PMID: 30218243 Free PMC article. Clinical Trial.
Total gastrectomy in patients with gastric adenocarcinoma: Is there an advantage to the minimally invasive approach?Surgery. 2019 Oct;166(4):623-631. doi: 10.1016/j.surg.2019.05.041. Epub 2019 Jul 17. Surgery. 2019. PMID: 31326190
The Impact of Minimally Invasive Gastrectomy on Survival in the USA.J Gastrointest Surg. 2019 May 31. doi: 10.1007/s11605-019-04263-4. Online ahead of print. J Gastrointest Surg. 2019. PMID: 31152343
Sutureless Aortic Valve Replacement for Treatment of Severe Aortic Stenosis: A Single Technology Assessment of Perceval Sutureless Aortic Valve [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25. Report from the Norwegian Institute of Public Health No. 2017-01. Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH). 2017. PMID: 29553663 Free Books & Documents. Review.
Minimally Invasive Versus Open Total Gastrectomy for Gastric Cancer: A Systematic Review and Meta-analysis of Short-Term Outcomes and Completeness of Resection : Surgical Techniques in Gastric Cancer.World J Surg. 2016 Jan;40(1):148-57. doi: 10.1007/s00268-015-3223-1. World J Surg. 2016. PMID: 26350821 Free PMC article. Review.